Mediplantex National Pharmaceutical JSC (HNX:MED)

HNX:MED Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25,001	42,611	43,534	81,183	46,107	53,183
Short-Term Investments	4,000	12,000	20,000	92,400	48,400	54,400
Cash & Short-Term Investments	29,001	54,611	63,534	173,583	94,507	107,583
Cash Growth	-51.45%	-14.04%	-63.40%	83.67%	-12.15%	58.29%
Accounts Receivable	41,738	66,896	90,917	127,297	113,221	187,497
Other Receivables	2,168	4,377	2,776	12,614	20,472	1,687
Receivables	43,906	71,273	93,693	139,911	133,694	189,185
Inventory	94,732	87,540	102,920	102,221	87,933	92,740
Prepaid Expenses	-	239.81	213.21	38.92	41.71	41.87
Other Current Assets	36,350	39,417	40,509	42,719	25,935	22,802
Total Current Assets	203,988	253,081	300,868	458,474	342,110	412,350
Property, Plant & Equipment	213,142	212,121	214,196	181,186	109,257	65,849
Other Intangible Assets	13.61	19.18	26.61	34.03	-	321.17
Other Long-Term Assets	40,320	38,534	40,152	58,793	42,271	44,331
Total Assets	457,464	503,755	555,243	698,487	493,638	522,852
Accounts Payable	42,332	77,962	74,430	84,885	41,394	72,142
Accrued Expenses	11,798	14,827	15,950	14,771	8,501	18,638
Short-Term Debt	49,865	27,787	64,463	90,835	68,595	80,606
Current Income Taxes Payable	2,451	948.94	651.91	2,393	1,430	1,484
Current Unearned Revenue	23,409	15,994	29,637	-	-	-
Other Current Liabilities	2,999	35,373	42,914	183,602	207,937	168,188
Total Current Liabilities	132,853	172,892	228,046	376,486	327,857	341,058
Total Liabilities	132,853	172,892	228,046	376,486	327,857	341,058
Common Stock	124,100	124,100	124,100	124,100	62,801	62,801
Additional Paid-In Capital	121,230	121,230	121,230	121,230	29,425	29,425
Retained Earnings	79,280	85,533	81,867	76,671	73,536	89,529
Comprehensive Income & Other	-	-	-	-	18.33	38.33
Shareholders' Equity	324,610	330,863	327,197	322,002	165,780	181,794
Total Liabilities & Equity	457,464	503,755	555,243	698,487	493,638	522,852
Total Debt	49,865	27,787	64,463	90,835	68,595	80,606
Net Cash (Debt)	-20,864	26,824	-929.58	82,748	25,912	26,976
Net Cash Growth	-	-	-	219.34%	-3.94%	-
Net Cash Per Share	-1682.06	2161.51	-74.91	8813.28	4128.39	4295.74
Filing Date Shares Outstanding	12.41	12.41	12.43	12.41	6.28	6.28
Total Common Shares Outstanding	12.41	12.41	12.43	12.41	6.28	6.28
Working Capital	71,135	80,189	72,822	81,988	14,253	71,292
Book Value Per Share	26157.17	26661.01	26331.15	25946.94	26397.75	28944.64
Tangible Book Value	324,597	330,844	327,170	321,968	165,780	181,472
Tangible Book Value Per Share	26156.07	26659.47	26329.01	25944.20	26397.75	28893.50
Buildings	47,111	47,111	47,111	-	-	-
Machinery	111,108	107,117	105,558	-	-	-
Construction In Progress	180,103	177,699	173,769	130,085	67,159	14,326

Source: S&P Global Market Intelligence. Standard template. Financial Sources.